ASSOCIATION BETWEEN ANTIHYPERTENSIVE AND LIPID-LOWERING THERAPY, BONE MASS, AND OSTEOPOROSIS RISK FACTORS
Aim. To evaluate the association between β-adrenoblocker (β-AB), angiotensin-converting enzyme inhibitor (ACEI), and statin therapy, bone mineral density (BMD), and osteoporosis risk factors (RFs).Material and methods. This retrospective study (n=1163) included 42 men and 1121 women aged >40...
Saved in:
| Main Authors: | K. E. Sobchenko, I. A. Skripnikova, V. E. Novikov, T. V. Popkova, I. S. Dydykina, A. V. Smirnov, V. A. Vygodin, E. L. Nasonov, S. A. Boytsov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01) -
Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength
by: I. A. Skripnikova, et al.
Published: (2019-03-01) -
TREATMENT ADHERENCE IN PATIENTS WITH OSTEOPOROSIS IN DAILY CLINICAL PRACTICE
by: N. V. Toroptsova, et al.
Published: (2014-06-01) -
The experience of the parenteral form of ibandrinic acid administration in different clinical situations of treatment of postmenopausal osteoporosis
by: L. A. Marchenkova, et al.
Published: (2021-06-01) -
OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)